Aguirre, Maricel .

HRN: 04-05-36  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/21/2026
CO-AMOXICLAV 625MG (TAB)
06/21/2026
06/28/2026
ORAL
625mg
BID
PROM; UTI
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: